MUC1 and cancer: Many of the MUC1-reactive antibodies reacted with peptide sequences in the TR domain, and the concept arose that in the cancer mucin, with shorter glycan chains, some of these peptide sequences were more exposed, thus explaining the tumour specificity of antibodies such as SM3 and DF3-P [17,18].